ESPLINE SARS-CoV-2 is for in vitro diagnostic (IVD) use with immunochromatographic assay for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.
ESPLINE SARS-CoV-2 is a cassette-style assay using a simple procedure without any special instruments. SARS-CoV-2 can be detected within 30 minutes.
Product number 231906
Click here to navigate
- Conditions of sale
- Related products
- Product inquiry
The 2019 novel coronavirus infection disease (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1,2 In December 2019, the Health Commission of the City of Wuhan, Hubei Province, China, reported multiple pneumonia patients with unknown cause. On January 7th 2020, the World Health Organization (WHO) announced that the National Health Commission of China identified a new type of coronavirus, SARS-CoV-2.3 The WHO declared a COVID-19 pandemic on March 11th 2020 due to the worldwide spread of novel coronavirus infection.4
The detection of viruses in the body of the patient is the most effective way of confirming SARS-CoV-2 infection. In most countries including Japan, the diagnosis of SARS-CoV-2 infection is based on the molecular detection of the SARS-CoV-2 genes. Though nucleic acid-based test can detect SARS-CoV-2 gene with high sensitivity, it is affected by the need of special equipment and the duration of reaction time.
- Wu F, et al. A new coronavirus associated with human respiratory disease in China Nature, 579: 265-269, 2020.
- Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndromerelated coronavirus: classifying 2019-nCoV and naming it SARS-CoV-Nat Microbiol, 5: 536-544, 2020.
- WHO website ”Rolling updates on coronavirus disease(COVID-19)” (https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-…) Medical Research and Development.
- WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020 (https://www.who.int/dg/speeches/detail/who-director-general-sopening-re…)
Conditions of sale
To read the end user conditions of sale for this product please visit our Resource center.
Lumipulse G SARS-CoV-2 Ag was the first high-sensitive nucleocapsid protein antigen assay launched on a fully automated chemiluminescent platform.
Jan 6, 2022
During this webinar Dr. Francesco Bonella (MD - Center for Interstitial & Rare Lung Disease, Department of Pulmonology, Ruhrlandklinik University...
Oct 19, 2020
Several fully automated and CLEIA-based LUMIPULSE G1200 systems from Fujirebio are right now performing fast, high sensitivity SARS CoV-2 antigen...
Aug 26, 2020
FAQHow does the coronavirus disease Covid-19 impact Fujirebio's operations?How does the coronavirus disease Covid-19 impact Fujirebio's operations?
iAMP COVID-19 Detection Kit
Product number 80767, 80762 -
Qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment.CE marked
iAMP COVID-19 SANO Assay
Product number 81104, 80762, 80812 -
Qualitative detection of nucleic acid from the SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal swabs and saliva specimens from individuals with signs and symptoms of infection who are suspected of COVID-19.CE marked
Lumipulse® G SARS-CoV-2 Ag
Product number 260340, 231869 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for detection and quantitative measurement of SARS-CoV-2 nucleocapsid protein antigen in human nasopharyngeal swab or saliva. As a diagnostic tool for the confirmation of a SARS-CoV-2 infection.CE marked
Lumipulse® G SARS-CoV-2 S-IgG
Product number 232231 -
For in vitro diagnostic (IVD) use with the Lumipulse G system for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology by a specific two-step immunoassay method on the LUMIPULSE G System.CE marked
Lumipulse® G KL-6 (Krebs von den Lungen)
Product number 233207 -
Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of sialylated carbohydrate antigen, KL-6 in serum or plasma.CE marked